Skip to content
Parakho

Q1 FY27, unaudited

Revenue
₹87.56 Cr
Profit after tax
₹8.28 Cr

As filed with the exchange, consolidated basis.

Statement of profit and loss

Figures in ₹ crore, reproduced from the results data files the company filed with NSE under Regulation 33 of the SEBI (LODR) Regulations. Nothing is restated, adjusted or estimated.

Statement of profit and loss, consolidated basis
₹ croreQ1 FY27vs a year agoFY26
Revenue from operations87.56171.97
Other income0.060.26
Total income87.62172.22
Employee benefit expense1.955.54
Finance costs0.923.74
Depreciation & amortisation1.071.52
Total expenses73.96129.71
Profit before tax13.6642.51
Tax expense5.3813.42
Profit after tax8.2829.09
Total comprehensive income8.2629.04
Earnings per share
Earnings per share, basic₹0.16₹6.11
Earnings per share, diluted₹0.16₹6.11

Q1 FY27 unaudited, from the company’s filing with NSE. Source

FY26 from the company’s filing with NSE. Source

Why the dash

Parakho has not ingested this company’s year-ago quarter, so the change column stays empty. A dash means we do not hold the figure — never that it is zero.

Earnings call

Q4 FY26

Anlon Healthcare reported FY26 consolidated total income of INR 172.22 crore, up 42.98% year-on-year, with EBITDA up 47.55% and PAT up 41.77%. Q4 FY26 total income was INR 50.90 crore versus INR 48.97 crore a year earlier, while reported PAT of INR 11.07 crore was lower than INR 16.65 crore in the year-ago quarter due to higher operating and development expenses. Management discussed the completed acquisitions of Apiqo Organics and Bizotic Life Science, capacity expansion plans, and provided revenue and margin outlook for FY27 and FY28.

Generated by AI from the filed transcript; every statement on the full page carries its verbatim quote. Read the cited summary

Filings

12 shown · 54 published by the exchange

BSE corporate announcements, classified by Parakho. The exchange’s own category is kept alongside our classification so a reclassification never rewrites history.

Page generated from filings held to 17 Aug 2026.